The middle child is quite normal; the other two are described below. Presentation. The first child, a girl, was born at term weighing 2-94 kg. Her mother was then 26 years old and pregnancy and delivery were normal She was well on breast and bottle feeds until the third day when she was lethargic and feeding poorly; blood glucose concentration was 11 mg/100 ml.
Investigations. An intravenous glucose tolerance test measuring also insulin and lactate showed (1) an inappropriately high fasting insulin level of 23 zU/ml (normal adult levels 3-20 jtU/ml) when her blood glucose was 9 mg/100 ml; and (2) a glucose disappearance rateof 2* 9mg/lOOmlpermin (normal 18). Every blood insulin test performed was higher than 20 ,uU/ml. Lactates were normal, as were the following: cultures for infection; urine for reducing substances; serum calcium, magnesium, and phosphate; leucine sensitivity test; and glucagon response test.
Treatment and progress. She was treated at first with glucagon and hydrocortisone with frequent feeds but blood sugars were only moderately maintained. Diazoxide (13 mg/kg per day) was substituted with hydrochlorothiazide to minimize sodium retention. By 11 weeks she showed evidence of seizures both clinically and on electroencephalogram, fits occurring even 528 when she was normoglycaemic. Phenytoin was added to her treatment. Her head circumference failed to increase adequately, falling from the 50th centile to the 5th centile, and she had poor auditory, visual, and social responsiveness.
Hypoglycaemia recurred during intercurrent infection and anorexia, so that at 6 months she had a laparotomy. No f-cell adenoma could be found so subtotal pancreatectomy (and incidental splenectomy) was performed. Postoperatively she had a short period of hyperglycaemia but then reverted to a near-hypoglycaemic state which now, however, was adequately controlled with diazoxide.
This was discontinued at 4j years of age after which it was found that an overnight fast no longer caused hypoglycaemia. Phenytoin was stopped at 6 years; she has had no fits since the age of 5 years. She is now mildly retarded but is a cheerful, pleasant, and much loved child, and attends a special school.
Histology ofpancreas. At the time of operation (1967) we were unaware of the condition. The histology was merely thought to show pleomorphism of the ,B-cell nuclei and poor granulation suggesting f-cell stimulation by an unknown agent. We hypothesized an insulinreleasing hormone produced from the gut such as has been described in rats (Turner and Marks, 1972) . Recent re-examination of the histology from this case shows diffuse hyperplasia of B (insulin-) and A (glucagon-producing) cells of the pancreas. Presentation. The third child, a boy, was born near term when his mother was 32 years old. Pregnancy and delivery were normal, birthweight 3-58 kg. He was breast-fed and appeared to do well; in view of the history of his sister, blood glucose levels were estimated from time to time using Dextrostix (Ames Co.). On day 3 a reading of 'less than 25 mg/100 ml' was found and a true blood glucose was 22 mg/100 ml. He was asymptomatic and no therapy other than a feed was given; 4 hours later he was pale, lethargic, cyanosed, and hypotonic. No colour registered on a Dextrostix test so after blood had been taken for true glucose estimation (later found to be 6 mg/100 ml) he was given intravenous glucose.
Investigations. An intravenous glucose tolerance test showed an inappropriately high fasting insulin level (21 juU/ml) when his blood glucose was 16 mg/100 ml. His urinary insulin excretion was very high, ,uU/mg creatinine (normal 1 * 25 tsU/mg creatinine).
As with his sister, other investigations were normal, including a leucine sensitivity test. Coeliac angiography performed before laparotomy showed no evidence of an insulinoma.
Treatment and progress. Initial attempts to control his hypoglycaemia included intravenous glucose, hydrocortisone, glucagon, and diazoxide, together with frequent milk feeds (with and without added sucrose). During this time he had both hypoglycaemic and normoglycaemic convulsions. The hypoglycaemia occurred more frequently on full-protein milk formula than on low-protein formula, suggesting at least a degree of protein-sensitivity (presumably not to branched chain amino acids since the leucine sensitivity test was normal). Full documentation of this protein-sensitivity did not seem justified since he was having recurrent hypoglycaemia, and at 15 weeks he had a laparotomy. No pancreatic tumour was palpable and the previous normal coeliac angiogram was confirmed by an injection of methylene blue. Subtotal pancreatectomy was therefore performed. The liver was grossly normal but to avoid hepatic damage due to possible leakage of pancreatic enzymes, no biopsy was taken.
His postoperative course was similar to his sister's. He was finally discharged at 19 weeks on a mediumprotein diet (2.2 g/kg per day) with sucrose, as well as diazoxide (9 mg/kg per day), hydrochlorothiazide (1-5 mg/kg per day), and phenobarbitone (9 mg/kg per day). By then his head circumference had fallen from the 90th centile at birth to <3rd centile; he had marked flexor head lag, hypertonia, and increased deep tendon reflexes, but good socialization.
He has required several hospitalizations for convulsions but general development has not been as slow as expected (for instance, he walked at 16 months). At age one year his protein restriction as well as his diazoxide were spontaneously discontinued by his mother, but no further hypoglycaemia has been observed.
Histology and histochemistry. Sections of pancreatic tissue from the first child were examined with fresh specimens from Case 2. Conventional histological stains (haematoxylin and eosin, aldehyde-fuchsin) showed the classical features described as nesidioblastosis (Yakovac et al., 1971) . Silver impregnation and lead haematoxylin stains for endocrine granules showed diffuse hyperplasia of all types.
Immunohistochemical studies, carried out with antibodies to insulin, glucagon, and gastrin, showed that islet cells were highly reactive to both insulin and glucagon. Specifically stained cells were seen in well-formed islets or scattered throughout the pancreas. In many locations ductal formation was seen. Very few and scattered gastrin immunoreactive cells were also seen (Fig.) . Ultrastructural studies, carried out on conventionally fixed tissue, showed the presence of four types of endocrine cells, A, B, D, and D1 (Wiesbaden Classification -Solcia et al., 1973) .
Discussion
To our knowledge this is the first report of nesidioblastosis in sibs. This raises interesting genetic and familial possibilities. Both sexes are represented so an autosomal recessive inheritance must be considered. The one normal child in the family, who was small-for-dates at birth (2-5 kg at 39 weeks' gestation) had no neonatal hypoglycaemia. The father has subsequently had convulsions thought to be hysterical in origin; another glucose tolerance test was normal. After counselling, the parents have decided not to have further children.
As in other reported cases (Yakovac et al., 1971; Grampa et al., 1974; Davidson et al., 1974; Sovik et al., 1975; Brown and Young, 1970) , both children presented clinically with hypoglycaemia in the presence of hyperinsulinism, and both responded to treatment with diazoxide which suppresses insulin release . Also, as previously described (Sovik et al., 1975; Hamilton et al., 1967) , subtotal pancreatectomy was required for complete control. We now feel that we should have proceeded to laparotomy immediately after initial investigations.
We believe this is the first report of this condition in which immunohistochemical methods have been used to show specific morphological evidence of the diffuse hyperplasia of the ( and sometimes a components of the pancreas. This visible evidence of insulin hyperplasia confirms one source of the raised serum insulin levels. Since these insulinproducing cells belong to the APUD series (Pearse, 1969) , other cells might be involved as a result of their common origin from the neural crest; nonetheless, in agreement with clinical findings, the insulin compartment shows the greatest degree of participation.
As has been pointed out (Gellis, 1973) 
